Lynn, MA, United States of America

Lillian M Smith

This inventor holds 1 USPTO granted patent. Top assignee: Eyetech Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lillian M Smith. Retrieved from https://idiyas.com/inventor/lillian-m-smith-rrhtxhv1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lillian M. Smith: Innovator in Nucleic Acid Detection

Introduction

Lillian M. Smith is a notable inventor based in Lynn, MA (US). She has made significant contributions to the field of molecular biology, particularly in the detection of modified nucleic acid oligonucleotides. Her innovative work has implications for diagnostics and therapeutics.

Latest Patents

Lillian holds 1 patent for her invention titled "Detection of oligonucleotides by dual hybridization." This invention provides methods and compositions for detecting and quantifying modified nucleic acid oligonucleotides. The methods are particularly useful for identifying synthetic modified oligonucleotides, such as aptamers, RNAi, siRNA, antisense oligonucleotides, or ribozymes in biological samples.

Career Highlights

Lillian is currently associated with Eyetech Inc., where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the field of nucleic acid detection.

Collaborations

Lillian has collaborated with notable colleagues, including David T. Shima and John P. Wing. These partnerships have further enhanced her research capabilities and contributions to the scientific community.

Conclusion

Lillian M. Smith's innovative work in the detection of modified nucleic acid oligonucleotides showcases her expertise and commitment to advancing molecular biology. Her contributions are vital for the development of diagnostic and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…